NuVasive commenced the commercial launch of Reline® Cervical, a new fixation system for posterior cervical fusion (PCF), in targeted regions.
Reline Cervical will allow surgeons to address complex PCF surgeries within one comprehensive fixation portfolio, as well as use the enabling technologies within Pulse. The compatibility of Reline Cervical with Pulse gives the support of navigation, imaging enhancement, intraoperative neuromonitoring, iGA® and patient-specific rod bending.
“Reline Cervical completes the foundational three strategic pillars of C360™—anterior cervical decompression and fusion, cervical total disc replacement, and now PCF. This launch is a significant step forward for our fixation portfolio and furthers our goal of becoming the market leader in complex deformity while extending our position with the industry’s leading cervical portfolio,” said Ryan Donahoe, chief technology officer at NuVasive. “We have leveraged our expertise with the proven Reline system, combined with Pulse®, to deliver our best PCF solution. The key advancements in this procedural technology fuel continued growth and differentiation in the cervical spine segment.”
NuVasive commenced the commercial launch of Reline® Cervical, a new fixation system for posterior cervical fusion (PCF), in targeted regions.
Reline Cervical will allow surgeons to address complex PCF surgeries within one comprehensive fixation portfolio, as well as use the enabling technologies within Pulse. The compatibility of Reline...
NuVasive commenced the commercial launch of Reline® Cervical, a new fixation system for posterior cervical fusion (PCF), in targeted regions.
Reline Cervical will allow surgeons to address complex PCF surgeries within one comprehensive fixation portfolio, as well as use the enabling technologies within Pulse. The compatibility of Reline Cervical with Pulse gives the support of navigation, imaging enhancement, intraoperative neuromonitoring, iGA® and patient-specific rod bending.
“Reline Cervical completes the foundational three strategic pillars of C360™—anterior cervical decompression and fusion, cervical total disc replacement, and now PCF. This launch is a significant step forward for our fixation portfolio and furthers our goal of becoming the market leader in complex deformity while extending our position with the industry’s leading cervical portfolio,” said Ryan Donahoe, chief technology officer at NuVasive. “We have leveraged our expertise with the proven Reline system, combined with Pulse®, to deliver our best PCF solution. The key advancements in this procedural technology fuel continued growth and differentiation in the cervical spine segment.”
Copy to clipboard 
